In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
January 2nd, 2006 | 20 | No |
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.01 | 0.66 | -10.83 | 6 | 6 | 0 | 127 | 270.244 | 0 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 3.71e-01 g/l | DrugBank-experimental |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CSK21-1-E | Casein Kinase II Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 350 | 0.45 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CSK21_HUMAN | P68400 | Casein Kinase II Alpha, Human | 350 | 0.45 | Binding ≤ 1μM |
CSK21_HUMAN | P68400 | Casein Kinase II Alpha, Human | 350 | 0.45 | Binding ≤ 10μM |
Description | Species |
---|---|
Condensation of Prometaphase Chromosomes | |
Signal transduction by L1 | |
WNT mediated activation of DVL |